Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Metastatic Melanoma with an Unknown Primary Origin Presenting with Postmenopausal Bleeding: A Case Report. (PubMed, Reports (MDPI)) - Sep 25, 2026 - "The patient underwent hysterectomy followed by adjuvant nivolumab...Because these lesions frequently present as polypoid, nodular, or infiltrative endometrial masses, prompt hysteroscopy and endometrial sampling are essential for diagnosis. This case highlights the importance of comprehensive histopathological evaluation and multidisciplinary management in rare presentations of metastatic melanoma." 
Journal • Endometrial Cancer • Gynecologic Cancers • Gynecology • Melanoma • Oncology • Ophthalmology • Skin Cancer • Solid Tumor • Uterine Cancer • Women's Health • SOX10
http://www.ncbi.nlm.nih.gov/pubmed/42784034
 
Abdullah N Maarouf; Bence Gabor Szilvasy; Nikolaj Warming; Nulvin Djebbara-Bozo
 
Sep 25, 2026
 
Prev Next